Figure 2.

Clinical characteristics of DRIFT2 participants. (A) From baseline to three months of the intervention, participants (n = 59) lost significant weight and waist circumference as shown in these violin plots. (B) Blood-based clinical health measures for DRIFT2 participants were assessed at baseline but not at three months. This tables shows the number of participants meeting each of the criteria for metabolic syndrome (MetS) at baseline (n = 56). (C) These violin plots show the distribution of metabolic syndrome (MetS) score (n = 56), which is the total number of components that define MetS that exceed the thresholds shown in (B), and of the components of MetS. BP: blood pressure; MetS: metabolic syndrome; HDL: high density lipoprotein.